4 news items
Immunome Appoints Sandra M. Swain to Board of Directors
IMNM
25 Apr 24
understanding of oncology and patient care will add a valuable perspective as we advance AL102 through Phase 3 and prepare Investigational New Drug (IND
Immunome to Present Preclinical Data for IM-3050, Its Lead Radioligand Therapy Candidate, at 2024 American Association for Cancer Research (AACR) Annual Meeting
IMNM
5 Apr 24
."
Immunome expects to submit an Investigational New Drug application to the U.S. Food & Drug Administration
Immunome Completes Acquisition of AL102, a Phase 3 Asset for the Treatment of Desmoid Tumors, From Ayala
IMNM
26 Mar 24
our preclinical programs towards Phase 1 trials."
AL102 is an investigational small molecule gamma
IMUNON, Inc. Announces IMNN-101 Preclinical Data In SARS CoV-2 Published In Peer-Reviewed Journal Vaccine
IMNM
22 Feb 24
-2 pathogens, and recent data from non-human primates are promising, we look forward to filing an Investigational New Drug (IND) application
- Prev
- 1
- Next